Brief: Arya Sciences Acquisition Corp Iv And Amicus Therapeutics, Inc. Mutually Agree To Terminate Business Combination Agreement With Respect To The Acquisition Of Amicus’ Gene Therapy Business Due To Market Conditions

Adagio Medical Holdings

24/02/2022 12:55

Feb 24 (Reuters) - ARYA Sciences Acquisition Corp IV
 ARYD.O :
    * ARYA SCIENCES ACQUISITION CORP IV AND AMICUS THERAPEUTICS,
INC.
MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENT WITH
RESPECT TO THE ACQUISITION OF AMICUS’ GENE THERAPY BUSINESS DUE
TO MARKET CONDITIONS
    * ARYA SCIENCES ACQUISITION IV CORP - STILL HAS OVER A YEAR
REMAINING TO IDENTIFY AND EXECUTE ON A BUSINESS COMBINATION
TRANSACTION
    * ARYA SCIENCES ACQUISITION IV CORP - NEITHER PARTY WILL BE
REQUIRED TO PAY OTHER A TERMINATION FEE

Source text for Eikon:  ID:nGNX7ydwPR 
Further company coverage:  ARYD.O 

 ((Reuters.Briefs@thomsonreuters.com;))